Speaker: Nouri Neamati is the John G. Searle Professor of Medicinal Chemistry at the University of Michigan College of Pharmacy. He obtained a Ph.D. in Biomedical Sciences from the University of Texas Graduate School of Biomedical Sciences and M.D. Anderson Cancer Center in Houston, Texas in 1995. From 1995 to 2000 he was a postdoctoral fellow and a research fellow at the National Institutes of Health. In September 2000, he joined the University of Southern California, School of Pharmacy with a joint appointment at the Norris Comprehensive Cancer Center and rose through the ranks to Full Professor in 2011. Dr. Neamati is the recipient of numerous awards including the NIH Technology Transfer Award, STOP CANCER Award, GlaxoSmithKline Drug Discovery Award, LUNGevity Discovery Award, American Lung Association, The Littlefield-AACR Award in Metastatic Colon Cancer Research. He has published over 290 peer-reviewed manuscripts, 20 book chapters, and over 40 patents in the area of drug design and discovery. He edited the first comprehensive book on "HIV-1 Integrase: Mechanism and Inhibitor Design". He has served innumerous study sections. He was the founding Editor-in-Chief of Current Molecular Pharmacology, an Associate Editor of Current Anticancer Drug Targets, and the Journal of Medicinal Chemistry and an Editorial Advisory Board member of several journals including Expert Opinion on Drug Discovery, Expert Opinion on Investigational Drugs, and Molecular Cancer Therapeutics.

Date: May 12, 2025

Time: 9:00-12:00 am

Location: Lecture Hall 501, Pharmaceutical Science Research Building, Baotuquan Campus, Shandong University

Sponsor: School of Pharmaceutical Sciences, Shandong University

For more information, please visit:

https://www.view.sdu.edu.cn/info/1020/201960.htm